Clinical Trial

Pathway-Matched Resilience-Oriented Therapy in Rwanda

Study acronym: RoT-CRT
Completed
View on ClinicalTrials.gov →
Summary
This pragmatic, pathway-stratified, cluster-randomized waitlist-controlled trial evaluated Resilience-Oriented Therapy (RoT), a culturally adapted group-based psychosocial intervention for post-genocide Rwanda. Community screening assigned eligible adults to one of three RoT variant pathways based on presenting profile: emotion regulation, identity development, or behavioural self-management. Within each pathway, local clusters were randomized to immediate RoT or waitlist control. The baseline cohort included 427 participants across 52 clusters in five Rwandan districts. Outcomes were assessed at baseline and immediate post-intervention endline from April to September 2023.
Trial Details
NCT Number NCT07621731
Lead Sponsor Alexandros Lordos, PhD
Collaborators: Centre for Sustainable Peace and Democratic Development, University of Rwanda, Interpeace
Conditions Mental Health, Psychological Trauma, Stress Disorders, Post-Traumatic, Depression, Anxiety, Aggression, Substance-related Disorders, Psychosocial Functioning
Enrollment 427 participants
Start Date 2023-04-28
Primary Completion 2023-09-15 (estimated)
Study Completion 2023-09-15 (estimated)
Updated on ClinicalTrials.gov 2026-06-02